HP eNews Update | 18 December 2018

AMS
www.menopause.org.au 18 December 2019
---
HP eNews

Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.
 

In this edition

 

December 2018

seasons greetings 2018

Insufficient nutrition during fetal development may lead to early menopause

Previous studies have demonstrated that fetal malnutrition can lead to adult chronic disorders such as type 2 diabetes and coronary artery disease. A new study out of China now suggests that it also can lead to early menopause and premature ovarian failure.

Infants are especially sensitive to changes in their environment while still in the womb, during their earliest stages of development. It has already been documented that the development of the hypothalamic-pituitary-gonadal axis during the fetal stage plays a critical role in adulthood reproductive health. Natural menopause is a milestone of ovarian aging that results in the end of a woman's reproductive years.

Although several studies have investigated the association between famine exposure in early life and risk of various metabolic diseases in adulthood, the association with reproductive aging was not evaluated. This new study involving nearly 2,900 Chinese women specifically sought to address the effect of early life exposure to famine on age at menopause.

The study concluded that prenatal famine was associated with a higher risk of early menopause (age younger than 45 years), as well as a higher risk of premature ovarian failure. Although study participants were born during China's infamous famine occurring between 1956 and 1964, the study provides valuable insights into the benefits of proper nutrition during early life stages for women of any culture.

read more

 

 

Menopause Management

AMS provides information for doctors and other health practitioners in supporting women through midlife health and the menopause and has arranged quick links to various subjects for your convenience.

  • Menopause Basics
    What is Menopause?
    Diagnosing Menopause 
    Menopause and Body Changes  
    Glossary of Terms

  • Menopause Treatment Options 
    Healthy Ageing and Lifestyle 
    Menopause Management GP Tool 
    Oestrogen Only Menopausal Hormone Therapy 
    Combined Menopausal Hormone Therapy (MHT) 
    Tibolone For Post-Menopausal Women 
    AMS Guide to Equivalent MHT/HRT Doses
    NonHormonal Treatments for Menopausal Symptoms

  • Early Menopause 
    Spontaneous Premature Ovarian Insufficiency
    Early Menopause due to Chemotherapy
    Surgical Menopause

  • Risks and Benefits 
    Risks and Benefits of MHT/HRT 
    Venous Thrombosis/Thromboembolism Risk and Menopausal Treatments

  • Uro-genital
    Stress and Urge Urinary Incontinence in Women
    Vulvovaginal symptoms after menopause
    Vaginal health after breast cancer: A guide for patients

  • Bones 
    Calcium Supplements – a patient guide
    Menopause and osteoporosis
    Prevention of falls and fractures as you age past the menopause
    SERMS after Menopause

  • Sex and Psychological 
    Sexual difficulties in the menopause 
    Sleep Disturbance and the Menopause 
    Mood problems at menopause - depression

  • Alternative Therapies 
    Complementary and Herbal Therapies for Hot Flushes
    Bioidentical Hormone Preparations - History of Development 
    Bioidentical Hormones for Menopausal Symptoms

  • Contraception
    Contraceptive methods, advantages and disadvantages

read more

 

 

Fact Sheets

The AMS website is often the first port of call for patients.

With this in mind AMS created set of fact sheets for patients, as companion sheets to the popular videos, and the other more detailed AMS Information Sheets.

Four Fact Sheets are currently available generally

  • Menopause what are the symptoms?
  • Non-hormonal treatment options for menopausal symptoms
  • What is Menopausal Hormone Therapy (MHT) and is it safe? 
  • Will menopause affect my sex life?
  • Complementary medicine options for menopausal symptoms

With regard to Complementary medicine options for menopausal symptoms we have provided both a colour version and a black and white version suitable for print.

Printable Fact Sheet

 

read more

 

 

Join AMS for Member's only content 

IMS Menopause Live: Consensus statement on urogenital atrophy

The British Menopause Society (BMS) has recently released an updated consensus statement on Urogenital atrophy [1]. The statement highlights the prevalence of this distressing condition amongst the postmenopausal population and draws attention to the fact that symptoms often present many years after the menopause and consequently are not always recognized as estrogen-deficient in origin, either by women or their practitioners. The statement also reviews the prevalence and patho-etiology of urogenital atrophy, including the impact this has on the bladder, urethra, uterosacral ligaments and other supporting structures. This often results in a variety of urinary symptoms, in particular symptoms of ‘pseudo-cystitis’ and recurrent urinary tract infections. The key to successful management of these conditions is recognizing the role estrogen has in maintaining the integrity of these structures, and a course of vaginal estrogens will often lead to a dramatic improvement in symptoms. The impact that urogenital atrophy or vulvovaginal atrophy (VVA) can have on sexual function and a woman’s sense of sexual well-being is well established... 

IMS Menopause Live: Fracture risk in younger women

WHI observational study: Fracture risk in younger women using the Garvan and FRAX Risk Calculators without DXA-derived BMD

Fracture risk assessment after menopause is generally advised. The study [1] applied risk assessment by FRAX and Garvan to 63723 women, aged 50-64 years, in the WHI observational study to predict hip fractures and major osteoporotic fractures (MOF) during a 10-year follow-up and to compare it to actual incidental fractures. The specificity of both tools for detecting incident hip fracture was low: Garvan 30.6% (95% confidence interval [CI] 30.3–31.0%) and FRAX 43.1% (95% CI 42.7–43.5%). Both models discriminated poorly between postmenopausal women aged 50–64 years who do and do not experience hip fracture, MOF or clinical fractures during a 10-year follow-up. Specificity was even worse in women of African American and Hispanic ethnicity... 

Our Menopause World December 2018

See all the news... including the following articles:

Risk of asthma onset after natural and surgical menopause: Results from the French E3N cohort.

Study background was that sex hormones have been suggested to play a role in the gender switch in asthma incidence around puberty; however, limited and inconsistent findings are present on the change in asthma incidence with menopause... 

Association of body mass index and age with subsequent breast cancer risk in premenopausal women

Study background was increasing body mass index (BMI) is associated with breast cancer risk reduction before and risk increase after menopause. The inverse association with premenopausal breast cancer risk is poorly characterized but may be important in the understanding of breast cancer causation... 

European Menopause and Andropause Society (EMAS)

AMS is an affiliate of EMAS. See a copy of the EMAS Newsletter December 2018 


---
AMS Congress 2018
---
Copyright © 2018
Australasian Menopause Society Ltd.
PO Box 280, Healesville, VIC 3777
Tel: +61 3 9428 8738 | Email: ams@menopause.org.au
Join the AMS now
Contact us |